Navigation Links
New drug to multiple sclerosis symptoms

A new drug AVP-923 is all set to provide relief to people suffering from the dreaded disease of multiple// sclerosis, said the researchers from University of Vermont College of Medicine, US.

Multiple sclerosis is a chronic neurological disease of the central nervous system. The disease affects the brain and spinal cord and medication till date had only been able to treat the problem symptomatically. One of the symptoms of this disease is called pseudobulbar affect is often characterized by episodes of laughter and crying in inappropriate situations. The outbursts are often spontaneous and the patients may have very little control over the expressions.

The new drug will be helping the patients to control much of their inappropriate emotional outbursts. The patients who were given the drug in the clinical trial had also reported of improvement in their quality of life, interpersonal relationships and physical comfort and pain. One of the side effects of the drug was reported to be spells of dizziness.

This is the first drug designed to specifically treat the condition of pseudobulbar affect in patients with multiple sclerosis. The results of the study was presented at the American Academy of Neurology 57th Annual Meeting, held on April 9-16.

Reference: American Academy of Neurology 57th Annual Meeting, Press Release
'"/>




Page: 1

Related medicine news :

1. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
2. Associated therapy for multiple myeloma
3. Latest drug shows promise in multiple myeloma
4. Vitamin D to reduce multiple sclerosis
5. Smoking may affect multiple sclerosis
6. Low immunity in people with multiple sclerosis may be genetical
7. Thalidomide is the new approved drug for treating multiple cancers
8. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
9. Calcium-blocker delays atherosclerosis than beta-blockers
10. Adult stem cells in treatment for Multiple sclerosis (MS)
11. Vitamin D to reduce multiple sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... SANTA CLARA, CA (PRWEB) , ... July 24, 2017 , ... ... government and financial organizations, today announced it has partnered with WALLIX to ... NIST Special Publication 800-171 . , There are a number of ways to address ...
(Date:7/24/2017)... ... July 24, 2017 , ... Anyone who uses scales know they ... would a pharmacist using that same scale to dispense medication. The first example is ... These illustrations show why it is important to have the right balance for the ...
(Date:7/24/2017)... ... 24, 2017 , ... A Southern California-based author has released a new book ... she has overcome them. “Forbidden Memories: A Memoir,” by author Michelle V. Madsen, highlights ... risen above. , In “Memories,” readers get a firsthand look at what Michelle has ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... how to change manufacturers future. , The agency is hammering out a game ... one of the farthest-ranging laws ever to affect FDA-regulated firms. The new law:, ...
(Date:7/24/2017)... ... 24, 2017 , ... “A Short Walk to the Mailbox”: a remarkable memoir ... of published author, Ed Clark. Ed Clark is a church music director and ... a minister of music and worship leader for over fifty years. He has ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... S.C. , July 10, 2017  BDI ... purchasing and patient support services organization serving specialty ... today the launch of four significant, value-added member ... market insights, better manage reimbursement and improve access ... and factor therapies. ...
(Date:7/5/2017)... 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... received approval from the Israel Securities Authority to dual-list its ... common stock will commence trading on the TASE on July ... market capitalization of the Company, it is expected that Oramed ...
(Date:6/30/2017)... -- AVACEN Medical (AVACEN) announced the publication of new research in the ... its AVACEN Treatment Method to significantly reduce the widespread ... ... ... approximately 200 to 400 million people worldwide according to The National ...
Breaking Medicine Technology: